Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma
Conditions: Kidney Cancer; Renal Cell Carcinoma; Renal Clear Cell Carcinoma Interventions: Drug: Anlotinib, Everolimus and Tislelizumab Sponsors: Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Clear Cell Carcinoma | Kidney Cancer | Renal Cell Carcinoma | Research | Urology & Nephrology